Using biology of disease to understand and guide therapy of JIA

Best Practice and Research: Clinical Rheumatology

Volumn 23, Issue 5, 2009, Pages 599-608

  Prakken, Berent J ^a,c   Albani, Salvatore ^b,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF ARIZONA   (United States)

^c Eureka Institute for Translational Medicine EU   (United States)

Author keywords

cytokines; heat shock proteins; immune therapy; immune tolerance; Juvenile Idiopathic Arthritis

Indexed keywords

AGGRECAN; AUTOANTIGEN; CALCIUM BINDING PROTEIN; CHEMOKINE; CYTOKINE; FIBRILLIN; HEAT SHOCK PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 10; MACROPHAGE MIGRATION INHIBITION FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; STROMELYSIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CHILD CARE; CLINICAL EFFECTIVENESS; DISEASE CLASSIFICATION; DISEASE MARKER; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; HEREDITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE FUNCTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYNOVIAL FLUID LEVEL; TARGET CELL; TREATMENT INDICATION;

ARTHRITIS, JUVENILE RHEUMATOID; AUTOIMMUNITY; BIOLOGICAL MARKERS; CHILD; CYTOKINES; HEAT-SHOCK PROTEINS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY;

EID: 72049121646     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2009.07.003     Document Type: Review

References (60)

1. Petty R.E., Southwood T.R., Manners P., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31 (2004) 390-392
2. Woo P., and Wedderburn L.R. Juvenile chronic arthritis. Lancet 351 (1998) 969-973
3. Thomson W., and Donn R. Juvenile idiopathic arthritis genetics-What's new? What's next?. Arthritis Res 4 (2002) 302-306
4. Heijstek M.W., Pileggi G.C., Zonneveld-Huijssoon E., et al. Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis 66 (2007) 1384-1387
5. Gonzalez B., Larrañaga C., León O., et al. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis. J Rheumatol 34 (2007) 1336-1340
6. Pancewicz S., Popko J., Rutkowski R., et al. Activity of lysosomal exoglycosidases in serum and synovial fluid in patients with chronic Lyme and rheumatoid arthritis. Scand J Infect Dis 9 (2009) 1-6
7. Zonneveld-Huijssoon E., Ronaghy A., Van Rossum M.A., et al. Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis. Arthritis Rheum 56 (2007) 639-646
8. Massa M., Mazzoli F., Pignatti P., et al. Proinflammatory responses to self-HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. Arthritis Rheum 46 (2002) 2721-2729
9. Bywaters E.G. Pathologic aspects of juvenile chronic polyarthritis. Arthritis Rheum 20 (1977) 271-276
10. Wynne-Roberts C.R., Anderson C.H., Turano A.M., and Baron M. Light- and electron microscopic findings of juvenile rheumatoid arthritis synovium: comparison with normal juvenile synovium. Semin Arthritis Rheum 7 (1978) 287-302
11. Silvermann E.D., Isacovics B., Petsche D., and Laxer D. Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue. Clin Exp Immunol 91 (1993) 90-95
12. Black A.P., Bhayani H., Ryder C.A., et al. T-cell activation without proliferation in juvenile idiopathic arthritis. Arthritis Res 4 (2002) 177-183
13. Murray K., Thompson S.D., and Glass D.N. Pathogenesis of juvenile chronic arthritis: genetic and environmental factors. Arch Dis Child 77 (1997) 530-534
14. Moroldo M.B., Donnelly P., Saunders J., et al. Transmission disequilibrium as a test of linkage and association between HLA alleles and pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 41 (1998) 1620-1624
15. Prahalad S., Ryan M.H., Shear E.S., et al. Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs. Arthritis Rheum 43 (2000) 2335-2338
16. Wedderburn L.R., Patel A., Varsani H., and Woo P. Divergence in the degree of clonal expansions in inflammatory T cell subpopulations mirrors HLA-associated risk alleles in genetically and clinically distinct subtypes of childhood arthritis. Int Immunol 13 (2001) 1541-1550
17. Nistala K., Moncrieffe H., Newton K.R., et al. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 58 (2008) 875-887
18. Poole A.R., Ionescu M., Swan A., and Dieppe P.A. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest 94 (1994) 25-33
19. Fischer D.C., Kolbe-Busch S., Stocker G., et al. Development of enzyme immunoassays specific for keratan sulphate- and core-protein-epitopes of the large aggregating proteoglycan from human articular cartilage. Eur J Clin Chem Clin Biochem 32 (1994) 285-291
20. Guerassimov A., Zhang Y., Banerjee S., et al. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. Arthritis Rheum 41 (1998) 1019-1025
21. Zou J., Zhang Y., Thiel A., et al. Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis. Rheumatology (Oxford) 42 (2003) 846-855
22. Zou J., Appel H., Rudwaleit M., et al. Analysis of the CD8 + T cell response to the G1 domain of aggrecan in ankylosing spondylitis. Ann Rheum Dis 64 (2005) 722-729
23. Kamphuis S., Hrafnkelsdóttir K., Klein M.R., et al. Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health. Arthritis Res Ther 8 (2006) R178
24. Waggett A.D., Kielty C.M., and Shuttleworth C.A. Microfibrillar elements in the synovial joint: presence of type VI collagen and fibrillin-containing microfibrils. Ann Rheum Dis 52 (1993) 449-453
25. Parks W.C., Wilson C.L., and Lopez-Boado Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4 (2004) 617-629
26. Gattorno M., Gerloni V., Morando A., et al. Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides. J Rheumatol 29 (2002) 1774-1779
27. ter Steege J., Vianen M., van Bilsen J, et al. Identification of self-epitopes recognized by T cells in rheumatoid arthritis demonstrates matrix metalloproteinases as a novel T cell target. J Rheumatol 30 (2003) 1147-1156
28. Van Bilsen J.H., Wagenaar-Hilbers J.P., Grosfeld-Stulemeijer M.C., et al. Matrix metalloproteinases as targets for the immune system during experimental arthritis. J Immunol 172 (2004) 5063-5068
29. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
30. de Kleer I.M., Wedderburn L.R., Taams L.S., et al. CD4 + CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172 (2004) 6435-6443
31. Ruprecht C.R., Gattorno M., Ferlito F., et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201 (2005) 1793-1803
32. Prakken B., Kuis W., van Eden W., and Albani S. Heat shock proteins in juvenile idiopathic arthritis: keys for understanding remitting arthritis and candidate antigens for immune therapy. Curr Rheumatol Rep 4 (2002) 466-473
33. Kamphuis S., Kuis W., de Jager W., et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 366 (2005) 50-56
34. Lee L., Buckley C., Blades M.C., et al. Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum 46 (2002) 2109-2120
35. Prakken B.J., Samodal R., Le T.D., et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci U S A 101 (2004) 4228-4233
36. Roncarolo M.G., Bacchetta R., Bordignon C., et al. Type 1 T regulatory cells. Immunol Rev 182 (2001) 68-79
37. O'Garra A., and Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 10 (2004) 801-805
38. Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 6 (2005) 338-344
39. Belkaid Y., and Rouse B.T. Natural regulatory T cells in infectious disease. Nat Immunol 6 (2005) 353-360
40. Alexander J., Sidney J., Southwood S., et al. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptide. Immunity 1 (1994) 751-761
41. Schett G., Tohidast-Akrad M., Steiner G., and Smolen J. The stressed synovium. Arthritis Res 3 (2001) 80-86
42. Gattorno M., Prigione I., Vignola S., et al. Levels of soluble CD27 in sera and synovial fluid and its expression on memory T cells in patients with juvenile idiopathic arthritides. Clin Exp Rheumatol 20 (2002) 863-866
43. Murray K.J., Grom A.A., Thompson S.D., et al. Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol 25 (1998) 1388-1398
44. Coutinho A., Hori S., Carvalho T., et al. Regulatory T cells: the physiology of autoreactivity in dominant tolerance and quality control of immune responses. Immunol Rev 182 (2001) 89-98
45. Read S., Malmstrom V., and Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192 (2000) 295-302
46. + T cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197 (2003) 111-119
47. + regulatory T cells control innate immune reactivity after injury. J Immunol 174 (2005) 2957-2963
48. Massa M., Passalia M., Manzoni S., et al. Differential Recognition of Heat-Shock Protein DnaJ-Derived Epitopes by Effector and Treg Cells Leads to Modulation of Inflammation in Juvenile Idiopathic Arthritis. Arthritis Rheum 56 (2007) 1648-1657
49. Fisson S., Djelti F., Trenado A., et al. Therapeutic potential of self-antigen-specific CD4 + CD25+ regulatory T cells selected in vitro from a polyclonal repertoire. Eur J Immunol 36 (2006) 817-827
50. Woo P., Wilkinson N., Prieur A.M., et al. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther 7 (2005) R1281-R1288
51. De Benedetti F., Meazza C., Vivarelli M., et al., British Paediatric Rheumatology Study Group. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 48 (2003) 1398-1407
52. de Jager W., Hoppenreijs E.P., Wulffraat N.M., et al. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 66 (2007) 589-598 Erratum in: Ann Rheum Dis 2008; 67: 280
53. Foell D., Wittkowski H., Vogl T., and Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81 (2007) 28-37
54. Vogl T., Tenbrock K., Ludwig S., et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13 (2007) 1042-1049
55. Foell D., Ichida F., Vogl T., et al. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet 361 (2003) 1270-1272
56. Albani S. Infection and molecular mimicry in autoimmune diseases of childhood. Clin Exp Rheumatol 12 (1994) S35-S41
57. Prakken B.J., van der Zee R., Anderton S.M., et al. Tolerance to an arthritogenic T-cell epitope of HSP65 and the regulation of experimental arthritis. Ann N Y Acad Sci 778 (1996) 425-426
58. Raz I., Elias D., Avron A., et al. Beta-cell function in new-onset type 1 diabetes and immunomodulation with heat-shock protein peptide (DiaPep277): a randomized, double-blind, phase II trial. Lancet 358 (2002) 1749-1753
59. Anderton S.M., and Wraith D.C. Selection and fine-tuning of the autoimmune T-cell repertoire. Nat Rev Immunol 2 (2002) 487-498
60. De Kleer I.M., Kamphuis S.M., Rijkers G.T., et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30 T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 48 (2003) 2001-2010